MJ Biologics, Inc. is a research company located in Mankato, Minnesota and is dedicated to the research and development of animal health products including autogenous MJPRRS® vaccine for PRRS control. Our commitment has now yielded MJ's 4th Generation Vaccine to be used as a tool to help producers minimize production losses and survive PRRSV challenges during this difficult economic environment.

MJPRRS® Technology demonstrated statistically significant results in a controlled heterologous pregnant gilt challenge trial presented at the 2010 Allen D. Leman Swine Conference, University of Minnesota, September 20, 2010 MJPRRS® vaccine is a cost-effective new tool in PRRS control in pregnant sows as well as nursery and grow-finish pigs. Many veterinarians are now recommending MJPRRS® vaccine in both pregnant sows and nursery-grow-finish pigs. Certain results from the field have shown noticeably improved herd health and reduced death loss.

• Current generation of autogenous killed MJPRRS® vaccine is a tool for PRRS stabilization and control in PRRS positive herds and is not designed for use as a stand alone vaccine in a PRRS naive herd.
  
  
• MJPRRS® vaccine is an autogenous vaccine exclusively produced, distributed, and sold by MVP Labs in Omaha Nebraska. MVP autogenous vaccines are produced in MVP’s licensed facilities and are only available through licensed veterinarians.
  
  
• MJPRRS® autogenous vaccine requires authorization for use by the attending veterinarian.

Patrick L. Graham M.S., DVM (2010) John McIntire, General Manager, and David Bishop, PhD
Pike Pig Systems
Pittsfield, Illinois

Mark Fitzsimmons, DVM (2010)
2006 Swine Practioner-of-the-Year

Paul J. Ambrecht, DVM (2010)
Lake City Veterinary Service
Lake City, Iowa

Keith Kinsley, DVM (2009)
Swine Health Center
Farwell, Minnesota

Brian Roggow, DVM
Fairmont Veterinary Clinic
Fairmont, Minnesota

Mark Wagner, DVM
Fairmont Veterinary Clinic
Fairmont, Minnesota